

Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1480-1481, 2005-01, pp. : 13-14
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Infliximab has an impact on psoriatic arthritis QOL
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 501, 2006-01 ,pp. :


Infliximab: Psoriasis associated with psoriatic arthritis: case report
Reactions Weekly, Vol. 1, Iss. 1411, 2012-01 ,pp. :


Expert Opinion on Investigational Drugs, Vol. 9, Iss. 7, 2000-07 ,pp. :


Adalimumab: In Psoriatic Arthritis
By Simpson Dene Scott Lesley J.
Drugs, Vol. 66, Iss. 11, 2006-01 ,pp. :